Gurm Hitinder S, Kooiman Judith, LaLonde Thomas, Grines Cindy, Share David, Seth Milan
Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.
Department of Thrombosis and Hemostasis and Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands.
PLoS One. 2014 May 9;9(5):e96385. doi: 10.1371/journal.pone.0096385. eCollection 2014.
Transfusion is a common complication of Percutaneous Coronary Intervention (PCI) and is associated with adverse short and long term outcomes. There is no risk model for identifying patients most likely to receive transfusion after PCI. The objective of our study was to develop and validate a tool for predicting receipt of blood transfusion in patients undergoing contemporary PCI.
Random forest models were developed utilizing 45 pre-procedural clinical and laboratory variables to estimate the receipt of transfusion in patients undergoing PCI. The most influential variables were selected for inclusion in an abbreviated model. Model performance estimating transfusion was evaluated in an independent validation dataset using area under the ROC curve (AUC), with net reclassification improvement (NRI) used to compare full and reduced model prediction after grouping in low, intermediate, and high risk categories. The impact of procedural anticoagulation on observed versus predicted transfusion rates were assessed for the different risk categories.
Our study cohort was comprised of 103,294 PCI procedures performed at 46 hospitals between July 2009 through December 2012 in Michigan of which 72,328 (70%) were randomly selected for training the models, and 30,966 (30%) for validation. The models demonstrated excellent calibration and discrimination (AUC: full model = 0.888 (95% CI 0.877-0.899), reduced model AUC = 0.880 (95% CI, 0.868-0.892), p for difference 0.003, NRI = 2.77%, p = 0.007). Procedural anticoagulation and radial access significantly influenced transfusion rates in the intermediate and high risk patients but no clinically relevant impact was noted in low risk patients, who made up 70% of the total cohort.
The risk of transfusion among patients undergoing PCI can be reliably calculated using a novel easy to use computational tool (https://bmc2.org/calculators/transfusion). This risk prediction algorithm may prove useful for both bed side clinical decision making and risk adjustment for assessment of quality.
输血是经皮冠状动脉介入治疗(PCI)的常见并发症,与短期和长期不良结局相关。目前尚无用于识别PCI术后最有可能接受输血患者的风险模型。我们研究的目的是开发并验证一种工具,用于预测当代PCI患者的输血情况。
利用45个术前临床和实验室变量开发随机森林模型,以估计PCI患者的输血情况。选择最具影响力的变量纳入简化模型。在独立验证数据集中,使用ROC曲线下面积(AUC)评估估计输血情况的模型性能,使用净重新分类改善(NRI)比较低、中、高风险类别分组后完整模型和简化模型的预测情况。评估不同风险类别中程序性抗凝对观察到的和预测的输血率的影响。
我们的研究队列包括2009年7月至2012年12月在密歇根州46家医院进行的103,294例PCI手术,其中72,328例(70%)被随机选择用于训练模型,30,966例(30%)用于验证。模型显示出良好的校准和区分能力(AUC:完整模型=0.888(95%CI 0.877-0.899),简化模型AUC=0.880(95%CI,0.868-0.892),差异p=0.003,NRI=2.77%,p=0.007)。程序性抗凝和桡动脉入路对中、高风险患者的输血率有显著影响,但在占总队列70%的低风险患者中未观察到临床相关影响。
使用一种新型易用的计算工具(https://bmc2.org/calculators/transfusion)可以可靠地计算PCI患者的输血风险。这种风险预测算法可能对床边临床决策和质量评估的风险调整都有用。